Terbinafine Nanohybrid: Proposing a Hydrogel Carrying Nanoparticles for Topical Release

10Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

A poloxamer 407 (P407)—Casein hydrogel was chosen to carry polycaprolactone nanoparticles carrying terbinafine (PCL-TBH-NP). In this study, terbinafine hydrochloride (TBH) was encapsulated into polycaprolactone (PCL) nanoparticles, which were further incorporated into a poloxamer-casein hydrogel in a different addition order to evaluate the effect of gel formation. Nanoparticles were prepared by the nanoprecipitation technique and characterized by evaluating their physicochemical characteristics and morphology. The nanoparticles had a mean diameter of 196.7 ± 0.7 nm, PDI of 0.07, negative ζ potential (−0.713 mV), high encapsulation efficiency (>98%), and did not show cytotoxic effects in primary human keratinocytes. PCL-NP modulated terbinafine was released in artificial sweat. Rheological properties were analyzed by temperature sweep tests at different addition orders of nanoparticles into hydrogel formation. The rheological behavior of nanohybrid hydrogels showed the influence of TBH-PCL nanoparticles addition in the mechanical properties of the hydrogel and a long-term release of the nanoparticles from it.

Cite

CITATION STYLE

APA

Tundisi, L. L., Ataide, J. A., da Fonseca, J. H. L., Silvério, L. A. L., Lancellotti, M., Paiva-Santos, A. C., … Mazzola, P. G. (2023). Terbinafine Nanohybrid: Proposing a Hydrogel Carrying Nanoparticles for Topical Release. Pharmaceutics, 15(3). https://doi.org/10.3390/pharmaceutics15030841

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free